Literature DB >> 17097905

European consensus table 2006 on botulinum toxin for children with cerebral palsy.

Florian Heinen1, Guy Molenaers, Charlie Fairhurst, Lucinda J Carr, Kaat Desloovere, Emmanuelle Chaleat Valayer, Edith Morel, Antigone S Papavassiliou, Kristina Tedroff, S Ignacio Pascual-Pascual, Günther Bernert, Steffen Berweck, Guiseppe Di Rosa, Elisabeth Kolanowski, Ingeborg Krägeloh-Mann.   

Abstract

An interdisciplinary group of experienced botulinum toxin users and experts in the field of movement disorders was assembled, to develop a consensus on best practice for the treatment of cerebral palsy using a problem-orientated approach to integrate theories and methods. The authors tabulated the supporting evidence to produce a condensed but comprehensive information base, pooling data and experience from nine European countries, 13 institutions and more than 5500 patients. The consensus table summarises the current understanding regarding botulinum toxin treatment options in children with CP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097905     DOI: 10.1016/j.ejpn.2006.08.006

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Authors:  Marissa Barlaan Lukban; Raymond L Rosales; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

3.  High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.

Authors:  Allison W Willis; Beth Crowner; Janice E Brunstrom; Abigail Kissel; Brad A Racette
Journal:  Dev Med Child Neurol       Date:  2007-11       Impact factor: 5.449

4.  Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Authors:  Megan Thorley; Samantha Donaghey; Priya Edwards; Lisa Copeland; Megan Kentish; Kim McLennan; Jayne Lindsley; Laura Gascoigne-Pees; Leanne Sakzewski; Roslyn N Boyd
Journal:  BMC Pediatr       Date:  2012-08-09       Impact factor: 2.125

Review 5.  Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.

Authors:  Richard Placzek; Dagmar Siebold; Julia F Funk
Journal:  Toxins (Basel)       Date:  2010-08-27       Impact factor: 4.546

Review 6.  Best clinical practice in botulinum toxin treatment for children with cerebral palsy.

Authors:  Walter Strobl; Tim Theologis; Reinald Brunner; Serdar Kocer; Elke Viehweger; Ignacio Pascual-Pascual; Richard Placzek
Journal:  Toxins (Basel)       Date:  2015-05-11       Impact factor: 4.546

7.  Relation of selective voluntary motor control of the lower extremity and extensor strength of the knee joint in children with spastic diplegia.

Authors:  Yasuaki Kusumoto; Kenji Takaki; Tadamitsu Matsuda; Osamu Nitta
Journal:  J Phys Ther Sci       Date:  2016-06-28

Review 8.  Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.

Authors:  Katharine E Alter; Barbara I Karp
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

9.  Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.

Authors:  Antigone S Papavasiliou; Irene Nikaina; Katerina Foska; Panagiotis Bouros; George Mitsou; Constantine Filiopoulos
Journal:  Toxins (Basel)       Date:  2013-03-12       Impact factor: 4.546

10.  Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment.

Authors:  Tufan Tarcan; Cem Akbal; Cağri A Sekerci; Tuncay Top; Ferruh Simşek
Journal:  Korean J Urol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.